Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring {Blood Glucose Meter, Lancet, and Strips}), Infectious Disease Testing {HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others}), Cardiometabolic Testing {Cardiac Troponin (cTn) Test, Myoglobin Test, and Others}), Pregnancy and Fertility Testing, Coagulation Testing, Tumor/Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities {Hospitals and Clinics, Diagnostic Centers, and Others}, Homecare, and Others) and Geography
The Point of Care Diagnostics Market is expected to reach US$ 88.83 Bn by 2031 from US$ 37.93 Bn in 2024; the market is estimated to grow at a CAGR of 13.0% during 2025-2031. Major factors driving the market growth include increasing prevalence of infectious diseases and key product launches and developments. However, product recalls among the market deterrents.
Point-of-care testing (POCT) is critical for the diagnosis, treatment, and prevention of infectious diseases. It can be used to detect major pathogens, including human immunodeficiency virus (HIV), malarial parasites, human papillomavirus (HPV), Ebola, dengue, and Zika viruses, and Mycobacterium tuberculosis (TB bacteria). According to the World Health Organization (WHO) data, 1.3 million people (including 214,000 individuals affected by HIV) succumbed to TB in 2022. Its estimates also indicate that 10.6 million individuals in the world will have TB in 2022, including 3.5 million women, 1.3 million children, and 5.8 million men. Additionally, 30 countries with high TB burdens contributed 86-90% of new TB cases during 2022. Eight countries contributed two-thirds of the total, with India leading the way, followed by the Philippines, China, Indonesia, Pakistan, Nigeria, Bangladesh, and South Africa. As per the WHO, HIV has infected over 39.9 million people worldwide. In 2023, people were diagnosed with HIV, out of which 1.3 million people were newly diagnosed, including 77% adults and 57% children. According to a study published by Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2023, ~630,000 people died due to HIV and associated conditions. As per the European Centre for Disease Prevention and Control, ~2.6 million people in Europe were infected with HIV in 2023. Healthcare-associated infections (HAIs), including central line-associated bloodstream infections and catheter-associated urinary tract infections (UTIs), might affect patients in hospitals and other healthcare facilities. According to WHO, ~9 million HAIs occur every year and cause nearly 25 million additional hospitalization days in Europe yearly. As per the same source, HAI leads to an additional financial burden of approximately US$ 14.0-26.0 billion in Europe each year. As per the Office of Disease Prevention and Health Promotion, 1 out of 31 hospitalizations in the US suffer from HAI at any given time. Thus, the increasing prevalence of infectious diseases is expected to create a demand for point-of-care test diagnostics worldwide.
The comparative company analysis evaluates and categorizes the point of care diagnostics market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Point of Care Diagnostics Market. The key market players are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Abbott Laboratories, QIAGEN NV, Siemens AG, BD, bioMerieux SA, Polymer Technology Systems, Inc. (PTS), Nova Biomedical Corporation, Danaher Corp
The point of care diagnostics market, based on product, is divided into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, thyroid testing, others. The glucose monitoring segment held the largest share of the Point of Care Diagnostics Market in 2024, and it is expected to register the highest CAGR during 2025-2031. Based on purchase mode, the point of care diagnostics market is segmented into OTC and Prescription. In 2024, the Prescription segment held the largest share of the market. Based on sample, the point of care diagnostics market is segmented into blood, urine, others. In 2024, the Blood segment held the largest share of the market. Based on end user, the point of care diagnostics market is segmented into healthcare facilities, homecare, and others. In 2024, the healthcare facilities segment held the largest share of the market.
Various organic and inorganic strategies are adopted by companies operating in the Point of Care Diagnostics Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Point of Care Diagnostics Market are listed below.
In July 2024, Roche the completion of the acquisition of LumiraDx’s Point of Care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organization.
Reason to buy
Point-of-care testing (POCT) is critical for the diagnosis, treatment, and prevention of infectious diseases. It can be used to detect major pathogens, including human immunodeficiency virus (HIV), malarial parasites, human papillomavirus (HPV), Ebola, dengue, and Zika viruses, and Mycobacterium tuberculosis (TB bacteria). According to the World Health Organization (WHO) data, 1.3 million people (including 214,000 individuals affected by HIV) succumbed to TB in 2022. Its estimates also indicate that 10.6 million individuals in the world will have TB in 2022, including 3.5 million women, 1.3 million children, and 5.8 million men. Additionally, 30 countries with high TB burdens contributed 86-90% of new TB cases during 2022. Eight countries contributed two-thirds of the total, with India leading the way, followed by the Philippines, China, Indonesia, Pakistan, Nigeria, Bangladesh, and South Africa. As per the WHO, HIV has infected over 39.9 million people worldwide. In 2023, people were diagnosed with HIV, out of which 1.3 million people were newly diagnosed, including 77% adults and 57% children. According to a study published by Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2023, ~630,000 people died due to HIV and associated conditions. As per the European Centre for Disease Prevention and Control, ~2.6 million people in Europe were infected with HIV in 2023. Healthcare-associated infections (HAIs), including central line-associated bloodstream infections and catheter-associated urinary tract infections (UTIs), might affect patients in hospitals and other healthcare facilities. According to WHO, ~9 million HAIs occur every year and cause nearly 25 million additional hospitalization days in Europe yearly. As per the same source, HAI leads to an additional financial burden of approximately US$ 14.0-26.0 billion in Europe each year. As per the Office of Disease Prevention and Health Promotion, 1 out of 31 hospitalizations in the US suffer from HAI at any given time. Thus, the increasing prevalence of infectious diseases is expected to create a demand for point-of-care test diagnostics worldwide.
The comparative company analysis evaluates and categorizes the point of care diagnostics market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Point of Care Diagnostics Market. The key market players are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Abbott Laboratories, QIAGEN NV, Siemens AG, BD, bioMerieux SA, Polymer Technology Systems, Inc. (PTS), Nova Biomedical Corporation, Danaher Corp
The point of care diagnostics market, based on product, is divided into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, thyroid testing, others. The glucose monitoring segment held the largest share of the Point of Care Diagnostics Market in 2024, and it is expected to register the highest CAGR during 2025-2031. Based on purchase mode, the point of care diagnostics market is segmented into OTC and Prescription. In 2024, the Prescription segment held the largest share of the market. Based on sample, the point of care diagnostics market is segmented into blood, urine, others. In 2024, the Blood segment held the largest share of the market. Based on end user, the point of care diagnostics market is segmented into healthcare facilities, homecare, and others. In 2024, the healthcare facilities segment held the largest share of the market.
Various organic and inorganic strategies are adopted by companies operating in the Point of Care Diagnostics Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Point of Care Diagnostics Market are listed below.
In July 2024, Roche the completion of the acquisition of LumiraDx’s Point of Care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organization.
Reason to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Point of Care Diagnostics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Point of Care Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Point of Care Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Infectious Diseases
5.2.2 Key Product Launches and Developments
5.3 Market Restraints
5.3.1 Product Recalls
5.4 Market Opportunities
5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies
5.5 Future Trends
5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
5.6 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Point of Care Diagnostics Market Forecast Analysis
7. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY PURCHASE MODE
8.1 OTC
8.1.1 Overview
8.1.2 OTC: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prescription
8.2.1 Overview
8.2.2 Prescription: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY SAMPLE
9.1 Blood
9.1.1 Overview
9.1.2 Blood: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Urine
9.2.1 Overview
9.2.2 Urine: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY END USER
10.1 Healthcare Facilities
10.1.1 Overview
10.1.2 Healthcare Facilities: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Homecare
10.2.1 Overview
10.2.2 Homecare: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
11. POINT OF CARE DIAGNOSTICS MARKET - GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Point of Care Diagnostics Market Overview
11.2.2 North America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product
11.2.3.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.2.3.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.2.3.3 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.2.3.4 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.4.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample
11.2.5.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User
11.2.6.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.2.6.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.2.7 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.2.7.1 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.2.7.2 United States: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.3 Canada: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.4 Mexico: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3 Europe
11.3.1 EuropePoint of Care Diagnostics Market Overview
11.3.2 Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.3.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.3.3.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.3.3.3 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.3.3.4 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.4.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.5.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.6.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.3.6.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.3.7 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.3.7.1 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.3.7.2 United Kingdom: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.3 Germany: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.4 France: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.5 Italy: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.6 Spain: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.7 Rest of Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4 Asia Pacific
11.4.1 Asia PacificPoint of Care Diagnostics Market Overview
11.4.2 Asia Pacific: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product
11.4.3.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.4.3.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.4.3.3 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.4.3.4 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.4.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample
11.4.5.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User
11.4.6.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.4.6.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.4.7 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.4.7.1 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.4.7.2 China: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.3 Japan: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.4 India: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.5 Australia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.6 South Korea: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.7 Rest of APAC: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5 Middle East and Africa
11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview
11.5.2 Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.5.7 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.5.7.2 South Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities 11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6 South and Central America
11.6.1 South and Central America Point of Care Diagnostics Market Overview
11.6.2 South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.3.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.6.3.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.6.3.3 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.6.3.4 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.4.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.5.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.6.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.6.6.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.6.7 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.6.7.1 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.6.7.2 Brazil: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.3 Argentina: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
14. COMPANY PROFILES
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Beckman Coulter Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bio-Rad Laboratories Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott Laboratories
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Johnson & Johnson
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Siemens AG
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BD
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Polymer Technology Systems, Inc. (PTS)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Nova Biomedical Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Talis Biomedical Corporation
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 QuidelOrtho Corp
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Chembio Diagnostics, Inc.
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Point of Care Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Infectious Diseases
5.2.2 Key Product Launches and Developments
5.3 Market Restraints
5.3.1 Product Recalls
5.4 Market Opportunities
5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies
5.5 Future Trends
5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
5.6 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Point of Care Diagnostics Market Forecast Analysis
7. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY PURCHASE MODE
8.1 OTC
8.1.1 Overview
8.1.2 OTC: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prescription
8.2.1 Overview
8.2.2 Prescription: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY SAMPLE
9.1 Blood
9.1.1 Overview
9.1.2 Blood: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Urine
9.2.1 Overview
9.2.2 Urine: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10. POINT OF CARE DIAGNOSTICS MARKET ANALYSIS - BY END USER
10.1 Healthcare Facilities
10.1.1 Overview
10.1.2 Healthcare Facilities: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Homecare
10.2.1 Overview
10.2.2 Homecare: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
11. POINT OF CARE DIAGNOSTICS MARKET - GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Point of Care Diagnostics Market Overview
11.2.2 North America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product
11.2.3.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.2.3.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.2.3.3 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.2.3.4 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.4.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample
11.2.5.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User
11.2.6.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.2.6.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.2.7 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.2.7.1 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.2.7.2 United States: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.3 Canada: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.4 Mexico: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3 Europe
11.3.1 EuropePoint of Care Diagnostics Market Overview
11.3.2 Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.3.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.3.3.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.3.3.3 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.3.3.4 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.4.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.5.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.6.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.3.6.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.3.7 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.3.7.1 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.3.7.2 United Kingdom: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.3 Germany: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.4 France: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.5 Italy: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.6 Spain: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.7 Rest of Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4 Asia Pacific
11.4.1 Asia PacificPoint of Care Diagnostics Market Overview
11.4.2 Asia Pacific: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product
11.4.3.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.4.3.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.4.3.3 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.4.3.4 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.4.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample
11.4.5.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User
11.4.6.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.4.6.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.4.7 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.4.7.1 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.4.7.2 China: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.3 Japan: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.4 India: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.5 Australia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.6 South Korea: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.7 Rest of APAC: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5 Middle East and Africa
11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview
11.5.2 Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.5.7 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.5.7.2 South Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities 11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6 South and Central America
11.6.1 South and Central America Point of Care Diagnostics Market Overview
11.6.2 South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.3.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
11.6.3.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
11.6.3.3 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
11.6.3.4 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.4.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.5.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.6.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
11.6.6.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
11.6.7 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.6.7.1 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
11.6.7.2 Brazil: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.3 Argentina: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
14. COMPANY PROFILES
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Beckman Coulter Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bio-Rad Laboratories Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott Laboratories
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Johnson & Johnson
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Siemens AG
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BD
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Polymer Technology Systems, Inc. (PTS)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Nova Biomedical Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Talis Biomedical Corporation
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 QuidelOrtho Corp
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Chembio Diagnostics, Inc.
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
